Back to Search
Start Over
1133P Additional practice-informing adverse event patterns and management in the KRYSTAL-1 phase II study of adagrasib (MRTX849) in patients with KRASG12C-mutated NSCLC.
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS1068-S1069. 2p. - Publication Year :
- 2022
- Subjects :
- *ADVERSE health care events
*NON-small-cell lung carcinoma
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159078042
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1257